Drug delivery device maker Nemera said that its Safe’n’Spray concept intranasal device has won the "Best Innovation In Drug Delivery Device" Award at Pharmapack. In addition to being a connected device that allows for usage monitoring and analysis, the Safe’n’Spray utilizes electronic fingerprint identification and locking to control dosing of potent drugs, with the … [Read more...] about Nemera’s Safe’n’Spray wins Pharmapack 2020 innovation award
Products and Services
Koura announces clinical trial plans for Zephex 152a
Koura (formerly Mexichem Fluor) announced that the FDA has cleared the company's IND for Zephex HFA 152a MDI propellant, and the company plans to initiate clinical trials of the propellant this month. In December 2019, Chiesi announced that it intended to bring a Zephex 152a inhaler to market by the end of 2025. At DDL 2016, Koura presented data suggesting the … [Read more...] about Koura announces clinical trial plans for Zephex 152a
Hovione Technology announces the receipt of patent grants for its TwinMax DPI
According to Hovione Technology, the company has received patent grants for its TwinMax large dose DPI in a number of new territories. CEO Peter Villax said, “We achieved unchallenged patent grants for TwinMax in the United States, Europe, Japan, China and other territories. Our patented TwinMax will enable pharmaceutical partners to license them and to develop and … [Read more...] about Hovione Technology announces the receipt of patent grants for its TwinMax DPI
CapMedic inhaler sensor gets FDA clearance
Cognita Labs has received FDA clearance for its CapMedic digital inhaler sensor for use with metered dose inhalers, the company said. The CapMedic device, which fits over the top of the MDI actuator and includes a built in spirometer, provides audio and visual instruction to patients to encourage correct inhaler use. The device also connects to a smartphone app, … [Read more...] about CapMedic inhaler sensor gets FDA clearance
Merxin launches DPI for generic Ellipta products
UK-based device company Merxin has officially launched its new MRX006 multidose DPI, which has dual cavities and is designed specifically for triple therapies such as generic versions of Trelegy Ellipta. The company introduced the new DPI at DDL 2019 and reported that it fielded numerous inquiries about the device. In 2019, the FDA indicated that Merxin's MRX001 … [Read more...] about Merxin launches DPI for generic Ellipta products
Impopharma acquired by Rubicon Research
Canadian CRO Impopharma, which specializes in OINDP analysis and development, has been acquired by Rubicon Research, Rubicon said. Impopharma's Concord, ON facility will become Rubicon's Nasal and Pulmonary Center of Excellence. Impopharma's services included testing and development of nasal sprays, MDIs, and DPIs. According to Rubicon, the company expects the … [Read more...] about Impopharma acquired by Rubicon Research
Nanoform applies for GMP certification
Finnish nanonization specialists Nanoform have filed for GMP certification with the Finnish Medicines Agency (FIMEA), the company said. In December 2018, Nanoform announced construction of a new GMP manufacturing facility in Helsinki. The company, which recently won the the 2019 Excellence in Pharma: Formulation award at CPhI, plans to offer GMP clinical … [Read more...] about Nanoform applies for GMP certification
Recipharm adds SprayView system to OINDP testing facility
CDMO Recipharm has announced an investment of $450,000 for installation of a Proveris Scientific SprayView Measurement System at its facility in Research Triangle Park, North Carolina. The company described the SprayView system as "an important tool that can visualize changes in other critical quality attributes (CQAs) of inhaled and nasal products" and said that it … [Read more...] about Recipharm adds SprayView system to OINDP testing facility
3M Drug Delivery Systems sold to Altaris Capital Partners
3M has announced the sale of "substantially all" of 3M Drug Delivery Systems to Altaris Capital Partners for approximately $650 million. 3M will keep a 17% interest in the new business, which is expected to employ approximately 900 of the current employees after the sale is completed. 3M's inhalation products include standard MDIs, a nasal MDI, and the Intelligent … [Read more...] about 3M Drug Delivery Systems sold to Altaris Capital Partners
Oxford Lasers opens contract aerosol imaging facility
Spray characterization specialists Oxford Lasers have opened a new contract services facility to provide drug delivery device testing at their site in Didcot, UK, the company said. Oxford Lasers Imaging Division Manager Seamus Murphy said, “This marks a new milestone for the Oxford Lasers Imaging division. We have been providing services and systems into the … [Read more...] about Oxford Lasers opens contract aerosol imaging facility